|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/551 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07D 213/42 | (2006.01) |
| (11) | Number of the document | 2170292 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08771562.9 |
| Date of filing the European patent application | 2008-06-20 | |
| (97) | Date of publication of the European application | 2010-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-08 |
| (46) | Date of publication of the claims translation | 2014-04-25 |
| (86) | Number | PCT/US2008/067622 |
| Date | 2008-06-20 |
| (87) | Number | WO 2009/002821 |
| Date | 2008-12-31 |
| (30) | Number | Date | Country code |
| 945701 P | 2007-06-22 | US |
| (72) |
KOO, Otilia, May, Yue, US
NIKFAR, Faranak, US
DIAZ, Steven, US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tabletuotos kompozicijos, turinčios atazanaviro |
| TABLETED COMPOSITIONS CONTAINING ATAZANAVIR |
| Payment date | Validity (years) | Amount | |
| 2025-05-19 | 18 | 347.00 EUR |
| 2026-06-20 |